- Home
- IGR vs MGTX Comparison
IGR vs MGTX Comparison
Compare IGR & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IGR | MGTX |
|---|---|---|
| Founded | 2004 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 645.2M | 610.1M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | IGR | MGTX |
|---|---|---|
| Price | $4.72 | $7.65 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 6 |
| Target Price | N/A | ★ $23.83 |
| AVG Volume (30 Days) | ★ 763.9K | 295.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 13.93% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $33,279,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $569.48 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 137.42 |
| 52 Week Low | $4.20 | $4.73 |
| 52 Week High | $5.37 | $9.73 |
Technical Indicators
Market Signals| Indicator | IGR | MGTX |
|---|---|---|
| Relative Strength Index (RSI) | 39.47 | 53.40 |
| Support Level | $4.65 | $7.23 |
| Resistance Level | $5.04 | $8.15 |
| Average True Range (ATR) | 0.08 | 0.34 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 22.22 | 78.73 |
Price Performance
Historical ComparisonAbout IGR CBRE Global Real Estate Income Fund of Beneficial Interest
CBRE Clarion Global Real Estate Income Fund is a United States-based diversified, closed-end management investment company. Its primary objective is high current income, and its secondary objective is capital appreciation. The fund invests a majority of its total assets in income-producing real estate securities, which includes common stocks, preferred securities, warrants, and convertible securities issued by real estate companies, such as real estate investment trusts. Under normal market conditions, it invests in real estate equity securities of companies domiciled predominantly in developed countries.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.